Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Tumor diagnosis reagent or kit based on detection of IGFBP-2 (insulin-like growth factor binding protein 2) autoantibody or combined detection of IGFBP-2 antoantibody and IGFBP-2, as well as application thereof

A technology of IGFBP-2 and autoantibodies, applied in measurement devices, instruments, scientific instruments, etc., can solve problems such as unsatisfactory diagnosis of early cancer

Active Publication Date: 2014-07-23
BEIJING CANCER HOSPITAL PEKING UNIV CANCER HOSPITAL +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, IGFBP-2 is not ideal for the diagnosis of early cancer, such as: glioma (22-25)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tumor diagnosis reagent or kit based on detection of IGFBP-2 (insulin-like growth factor binding protein 2) autoantibody or combined detection of IGFBP-2 antoantibody and IGFBP-2, as well as application thereof
  • Tumor diagnosis reagent or kit based on detection of IGFBP-2 (insulin-like growth factor binding protein 2) autoantibody or combined detection of IGFBP-2 antoantibody and IGFBP-2, as well as application thereof
  • Tumor diagnosis reagent or kit based on detection of IGFBP-2 (insulin-like growth factor binding protein 2) autoantibody or combined detection of IGFBP-2 antoantibody and IGFBP-2, as well as application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0067] The following examples illustrate the present invention in more detail, but this does not mean that the protection scope of the present invention is limited by these examples.

[0068] An overview of embodiments of the invention follows.

[0069] Study patients and research methods: Glioma and colorectal tumor were used as research models. Serum IGFBP-2 and IGFBP-2 autoantibody concentrations were detected in 260 cancer patients (145 glioma patients, 45 colorectal polyposis patients and 70 colorectal tumor patients). ROC curves were used to assess diagnostic ability.

[0070] Results: Compared with the serum IGFBP-2-Abs concentration of the normal control group (mean: 11ng / ml, median: 0ng / ml, range: 0-212ng / ml), the serum IGFBP-2 autoantibody concentration (IGFBP- 2-Abs) was significantly increased in tumors (mean: 82ng / ml, median: 17ng / ml, range: 0-1387ng / ml) (P<0.0001), and its concentration was higher in the serum of early cancer patients, Contrary to the concentr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention provides a tumor diagnosis reagent or kit based on detection of an IGFBP-2 (insulin-like growth factor binding protein 2) autoantibody or combined detection of the IGFBP-2 autoantibody IGFBP-2. The tumor diagnosis reagent or kit comprises a first reagent group capable of detecting the IGFBP-2 autoantibody in a detected sample, or a first reagent group capable of detecting the IGFBP-2 autoantibody in the detected sample and a second reagent group capable of detecting IGFBP-2 in the detected sample. The invention also provides application of IGFBP-2 autoantibody detection or combined detection of the IGFBP-2 autoantibody and the IGFBP-2 in preparing the tumor diagnosis reagent or kit. Detection of the IGFBP-2 autoantibody can be used for diagnosing early-phase tumor or high-grade adenoma with cancerization risk, in particular for diagnosing prometaphase glioma and high-grade colorectal polyp and / or colorectal neoplasms of I-II grades with cancerization risk; and the combined detection of the IGFBP-2 autoantibody and the IGFBP-2 can be used for diagnosing tumors of different grades and monitoring each phase of a tumor from low grade to high grade, such as diagnosing and identifying astrocytoma, anaplastic astrocytoma and / or spongioblastoma, as well as I-IV grades of colorectal neoplasms.

Description

technical field [0001] The present invention relates to a tumor diagnostic reagent or kit based on the detection of IGFBP-2 autoantibodies (IGFBP-2-Abs) or its combination with IGFBP-2, and the detection of IGFBP-2 autoantibodies or its combination with IGFBP-2 The application of combined detection in the preparation of tumor diagnostic reagents or kits. Specifically, the detection of IGFBP-2 autoantibodies in the present invention can diagnose early-stage tumors or high-grade adenomas with cancer risk, especially early and middle-stage gliomas and high-grade colorectal polyps with cancer risk and / or Or colorectal tumor grade I-II, the combined detection of IGFBP-2 autoantibody and IGFBP-2 can diagnose tumors of different grades and monitor the various stages of tumor progression from low grade to high grade, such as diagnosis and identification of astrocytes Glioblastoma, anaplastic astrocytoma, and / or glioblastoma, and colorectal tumors grades I-IV. Background technique ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/574
Inventor 宋韦江涛李雨晨张靖
Owner BEIJING CANCER HOSPITAL PEKING UNIV CANCER HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com